ADNP and Parkinson disease: Among the 29 TFs activated in male PD patients, ADNP, JUN, MBD3, PRDM14, and ESR1 have known associations with neurodegenerative disorders such as Alzheimer's disease, mental retardation, schizophrenia, and autism.